Literature DB >> 412677

The effects of industrial lead poisoning on cytochrome P450 mediated phenazone (antipyrine) hydroxylation.

P A Meredith, B C Campbell, M R Moore, A Goldberg.   

Abstract

In a group of ten male adults admitted to hospital with clinical symptoms of lead exposure, phenazone, elimination rates, blood delta-amino-laevulinic acid dehydratase (ALA.D) activity, blood lead levels and haemoglobin were measured. Investigations were carried out before, immediately after and again at least 12 weeks after cessation of CaEDTA (sodium calcium edetate) chelation therapy. Following chelation, phenazone elimination rates were increased as assessed by a decrease in half life and increase in clearance. This was significant, both immediately after and 12 weeks after cessation of chelation therapy. The change in rate of phenazone metabolism was associated with improved clinical status, with lowered blood lead levels and raised haemoglobin and ALA.D activity. The results of the study suggest that the depression in phenazone elimination in lead intoxication is possibly due to depressed hepatic cytochrome P450 levels.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412677     DOI: 10.1007/bf00609867

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.

Authors:  E S Vesell; G T Passananti; P A Glenwright; B H Dvorchik
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

2.  Elimination of antipyrine from saliva as a measure of metabolism in man.

Authors:  R M Welch; R L DeAngelis; M Wingfield; T W Farmer
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

3.  Haem biosynthesis and hydroxylation of phenazone during lead intoxication.

Authors:  B C Campbell; P A Meredith; M R Moore; M J Brodie; G G Thompson; A Goldberg
Journal:  Biochem Soc Trans       Date:  1976       Impact factor: 5.407

4.  The estimation of antipyrine in biological materials.

Authors:  B B BRODIE; J AXELROD
Journal:  J Biol Chem       Date:  1949-05       Impact factor: 5.157

5.  Comparison of plasma levels of antipyrine, tolbutamide, and warfarin after oral and intravenous administration.

Authors:  P B Andreasen; E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

6.  European standardized method for the determination of delta-aminolevulinic acid dehydratase activity in blood.

Authors:  A Berlin; K H Schaller
Journal:  Z Klin Chem Klin Biochem       Date:  1974-08

Review 7.  Lead poisoning and haem biosynthesis.

Authors:  A Goldberg
Journal:  Br J Haematol       Date:  1972-11       Impact factor: 6.998

8.  Hepatic drug metabolizing activity in lead-poisoned rats.

Authors:  P Scoppa; M Roumengous; W Penning
Journal:  Experientia       Date:  1973-08-15

9.  Drug metabolism in normal children, lead-poisoned children, and normal adults.

Authors:  A P Alvares; S Kapelner; S Sassa; A Kappas
Journal:  Clin Pharmacol Ther       Date:  1975-02       Impact factor: 6.875

10.  Lead and methyl mercury: effects of acute exposure on cytochrome P-450 and the mixed function oxidase system in the liver.

Authors:  A P Alvares; S Leigh; J Cohn; A Kappas
Journal:  J Exp Med       Date:  1972-06-01       Impact factor: 14.307

View more
  11 in total

1.  The association between occupational lead exposure and serum cholesterol and lipoprotein levels.

Authors:  E Kristal-Boneh; D Coller; P Froom; G Harari; J Ribak
Journal:  Am J Public Health       Date:  1999-07       Impact factor: 9.308

Review 2.  Research review. Interactions between environmental chemicals and drug biotransformation in man.

Authors:  A P Alvares
Journal:  Clin Pharmacokinet       Date:  1978 Nov-Dec       Impact factor: 6.447

3.  CYP2E1 activity and children with obesity: possible confounding factors.

Authors:  Hardeep Kaur; Phulen Sarma; Ajay Prakash; Bikash Medhi
Journal:  Br J Clin Pharmacol       Date:  2018-10-17       Impact factor: 4.335

4.  Hepatic drug metabolism and haem biosynthesis in lead-poisoned rats.

Authors:  A Goldberg; P A Meredith; S Miller; M R Moore; G G Thompson
Journal:  Br J Pharmacol       Date:  1978-04       Impact factor: 8.739

Review 5.  Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives.

Authors:  M Døssing
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

Review 6.  The carcinogenicity of lead.

Authors:  M R Moore; P A Meredith
Journal:  Arch Toxicol       Date:  1979-06-08       Impact factor: 5.153

7.  Steroid hormone sulphation in lead workers.

Authors:  P Apostoli; L Romeo; E Peroni; A Ferioli; S Ferrari; F Pasini; F Aprili
Journal:  Br J Ind Med       Date:  1989-03

8.  Alteration of steroid hormone sulfation and D-glucaric acid excretion in lead workers.

Authors:  A Ferioli; P Apostoli; L Romeo
Journal:  Biol Trace Elem Res       Date:  1989 Jul-Sep       Impact factor: 3.738

9.  Evidence for concurrent effects of exposure to environmental cadmium and lead on hepatic CYP2A6 phenotype and renal function biomarkers in nonsmokers.

Authors:  Soisungwan Satarug; Muneko Nishijo; Pailin Ujjin; Yuvaree Vanavanitkun; Jason R Baker; Michael R Moore
Journal:  Environ Health Perspect       Date:  2004-11       Impact factor: 9.031

10.  A novel hypothesis for atherosclerosis as a cholesterol sulfate deficiency syndrome.

Authors:  Stephanie Seneff; Robert M Davidson; Ann Lauritzen; Anthony Samsel; Glyn Wainwright
Journal:  Theor Biol Med Model       Date:  2015-05-27       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.